http://finance.yahoo.com/news/cvs-caremark-buy-coram-2-143453305.html
Just wait until CVS/Caremark uses their “efficiency formula” on the home IV business…
There is more profits in “high risk non-sterile to sterile compounding” Remember the NECC fiasco ?
quoted from Pharmacist Steve
No comments:
Post a Comment